Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Analyses of Patient-reported Outcomes and Quality-adjusted Time Without Symptoms or Toxicity from the JAVELIN Bladder 100 Trial

  • Petros Grivas
  • , Jeanny B. Aragon-Ching
  • , Joaquim Bellmunt
  • , Yohann Loriot
  • , Miguel A. Climent Duran
  • , Srikala S. Sridhar
  • , Po Jung Su
  • , Se Hoon Park
  • , Evgeny Kopyltsov
  • , Yoshiaki Yamamoto
  • , Natalia Jacob
  • , Jason Hoffman
  • , Karin Tyroller
  • , Juliane Manitz
  • , Mairead Kearney
  • , Michael Schlichting
  • , Thomas Powles

Research output: Contribution to journal › Article › peer-review

1   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Analyses of Patient-reported Outcomes and Quality-adjusted Time Without Symptoms or Toxicity from the JAVELIN Bladder 100 Trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science